Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial
A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.
Zepbound Shows 47% Greater Weight Loss Than Wegovy in Obesity Trial
A clinical trial showed that adults using the obesity drug Zepbound lost 47% more weight on average than those using Wegovy after 18 months, achieving an average weight loss of 50 pounds compared to 33 pounds, respectively.
Progress
48% Bias Score
El auge de fármacos contra la obesidad reduce las cirugías bariátricas en Estados Unidos
El uso de agonistas del receptor GLP-1 para tratar la obesidad aumentó un 123% en Estados Unidos entre 2022 y 2023, mientras que las cirugías bariátricas disminuyeron un 25%, planteando un cambio en las estrategias terapéuticas y la necesidad de evaluar la combinación de ambos tratamientos.
El auge de fármacos contra la obesidad reduce las cirugías bariátricas en Estados Unidos
El uso de agonistas del receptor GLP-1 para tratar la obesidad aumentó un 123% en Estados Unidos entre 2022 y 2023, mientras que las cirugías bariátricas disminuyeron un 25%, planteando un cambio en las estrategias terapéuticas y la necesidad de evaluar la combinación de ambos tratamientos.
Progress
40% Bias Score
Wegovy Launches in China
The weight-loss drug Wegovy launches in China, offering a potentially effective treatment for the country's large obese population, but also raising questions about affordability and healthcare systems.
Wegovy Launches in China
The weight-loss drug Wegovy launches in China, offering a potentially effective treatment for the country's large obese population, but also raising questions about affordability and healthcare systems.
Progress
40% Bias Score
Losing the Last 5kg: Challenges and Solutions
A book review focusing on "5 in 4: The Art and Science of Losing Those Last Few Kilos", detailing challenges and solutions for weight loss.
Losing the Last 5kg: Challenges and Solutions
A book review focusing on "5 in 4: The Art and Science of Losing Those Last Few Kilos", detailing challenges and solutions for weight loss.
Progress
24% Bias Score
Trial for Fake Weight-Loss Injections in Austria
Two men stand trial in Austria for selling fake weight-loss injections to a plastic surgeon, resulting in serious health consequences for one victim. The injections contained insulin instead of the intended active ingredient.
Trial for Fake Weight-Loss Injections in Austria
Two men stand trial in Austria for selling fake weight-loss injections to a plastic surgeon, resulting in serious health consequences for one victim. The injections contained insulin instead of the intended active ingredient.
Progress
36% Bias Score
Ozempic and Weight Loss: A Critical Look
Dr. Sanjay Gupta explores the effectiveness and implications of Ozempic and similar weight-loss drugs, addressing the debate around obesity's classification and the importance of lifestyle changes.
Ozempic and Weight Loss: A Critical Look
Dr. Sanjay Gupta explores the effectiveness and implications of Ozempic and similar weight-loss drugs, addressing the debate around obesity's classification and the importance of lifestyle changes.
Progress
0% Bias Score
Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Zepbound Outperforms Wegovy in 72-Week Weight Loss Trial
A new, yet un-peer-reviewed study shows Eli Lilly's Zepbound (tirzepatide) enabled 20% weight loss in 72 weeks among 751 obese or overweight participants, exceeding Wegovy's (semaglutide) under 14% weight loss; this translates to approximately 50 pounds lost with Zepbound versus 33 pounds with Wegov...
Progress
40% Bias Score
Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.
Weight-Loss Drugs: Successes and Side Effects
This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.
Progress
24% Bias Score
Protein and Health
This article discusses the importance of protein in our diet, explaining its various functions, types, recommended intake, and potential effects of high-protein diets.
Protein and Health
This article discusses the importance of protein in our diet, explaining its various functions, types, recommended intake, and potential effects of high-protein diets.
Progress
24% Bias Score
Healthcare Worker Nearly Dies After Using 'Skinny Jabs' from Facebook
A healthcare worker almost died after injecting weight-loss jabs bought on Facebook, raising concerns about the dangers of unregulated medications.
Healthcare Worker Nearly Dies After Using 'Skinny Jabs' from Facebook
A healthcare worker almost died after injecting weight-loss jabs bought on Facebook, raising concerns about the dangers of unregulated medications.
Progress
40% Bias Score
Kelly Osbourne's Birthday Celebrations and Weight Loss Comments
Kelly Osbourne celebrated her son's birthday with a star-studded party and recently celebrated her own birthday with a glamorous event. She also addressed rumors surrounding her weight loss.
Kelly Osbourne's Birthday Celebrations and Weight Loss Comments
Kelly Osbourne celebrated her son's birthday with a star-studded party and recently celebrated her own birthday with a glamorous event. She also addressed rumors surrounding her weight loss.
Progress
40% Bias Score
UK Trials Weight-Loss Drugs to Combat Unemployment
The UK is trialing Eli Lilly's weight-loss drugs to determine if they can reduce unemployment by improving the health of economically inactive individuals.
UK Trials Weight-Loss Drugs to Combat Unemployment
The UK is trialing Eli Lilly's weight-loss drugs to determine if they can reduce unemployment by improving the health of economically inactive individuals.
Progress
0% Bias Score